COVID-19 Patients Admitted to the ICU
- Conditions
- Covid19
- Interventions
- Other: no intervention will be administered, this is a retrospective observational study.
- Registration Number
- NCT04816786
- Lead Sponsor
- Ministry of Health, Kuwait
- Brief Summary
A retrospective analysis of the adult COVID-19 patients admitted to the ICU. A chart review will be conducted and multiple baseline characteristics, demographics, and treatments given will be recorded.
Variables collected will include Age, Gender, BMI, Smoking status, Past medical history, Vital signs on admission, symptoms on admission, duration of symptoms, laboratory results on admission, treatment given. Treatment options will include (Steroids, plasma exchange, IVIG, antibiotics, mode of respiratory support).
Primary outcomes will include; Death, duration of ICU stay, duration of mechanical ventilation, in-hospital complications.
A regression model will be used to predict poor prognostic factors. Inclusion criteria: patients with confirmed PCR results for COVID-19 AND require ICU admission. Exclusion criteria: those with negative results, pediatric patients and those not requiring ICU admission.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
- Adults
- Positive PCR test for COVID-19
- Require admission to ICU
- Pediatric patients\
- Any patient not requiring admission to ICU
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Group 1: Admitted to ICU and died during the hospital stay. no intervention will be administered, this is a retrospective observational study. - Group 2: Admitted to ICU was were discharged. no intervention will be administered, this is a retrospective observational study. -
- Primary Outcome Measures
Name Time Method Death 30 day mortality Death Vs No Death
Duration of mechanical ventilation 30 days The duration the patient required support from a mechanical ventilator
Duration of ICU stay 30 days Duration of ICU stay
- Secondary Outcome Measures
Name Time Method In-Hospital complications 30 days Wether patients developed in hospital complications.
Trial Locations
- Locations (1)
Mubarak al Kabeer hospital
🇰🇼Kuwait, Outside U.S./Canada, Kuwait